Cold agglutinin disease
Cold agglutinin disease
Also known as:CAD, cold antibody autoimmune hemolytic anemia, China Second Rare Disease Catalog item 15
Cold agglutinin disease is a rare autoimmune hemolytic anemia in which cold-triggered antibodies can lead to red blood cell destruction, anemia, jaundice, dark urine, and cold-induced color changes in the hands or feet.
Start Here
A quick guide to the next step: which department to start with, what to prepare, and what to ask.
Recurrent anemia, jaundice, dark urine, or cold-induced blue or pale painful extremities should be evaluated by hematology. Severe shortness of breath, chest pain, confusion, or infection signs need emergency care.
Cold agglutinins are autoantibodies that bind red blood cells more readily at lower temperatures and can activate complement, causing hemolysis. People may have anemia symptoms and cold-related color change or pain in fingers, toes, ears, or nose.
Mild disease may be managed with warmth, cold avoidance, infection prevention, and monitoring. Symptomatic anemia, transfusion dependence, or severe circulatory symptoms may need hematology-directed B-cell therapy, complement-directed therapy, or other treatment.
CAD is usually not inherited. Clinicians assess whether it is primary CAD or secondary to infection, autoimmune disease, lymphoproliferative disease, or another condition.
CAD may be mistaken for common anemia, Raynaud-like symptoms, cold hands and feet, or post-infection fatigue. Linking anemia, hemolysis labs, direct antiglobulin testing, and cold-triggered symptoms is key.
This page helps patients and families organize care leads. It does not replace a clinician’s diagnosis or treatment plan. For testing, medication, referrals, emergency care, and support applications, follow qualified clinicians, medical institutions, support organizations, and official sources.
Diagnosis Path
Organized around the practical patient journey: identify clues, avoid common delays, then prepare for care.
When to Suspect It
- Fatigue, dizziness, palpitations, or shortness of breath recur with anemia and hemolysis clues such as high bilirubin or LDH and low haptoglobin.
- Fingers, toes, ears, or nose turn blue or pale, painful, or numb after cold exposure.
- Dark urine or jaundice worsens in cold weather, after cold drinks or infusions, or after infection.
- Blood samples clump, CBC results are hard to interpret, or the direct antiglobulin test suggests complement involvement.
Common Wrong Turns
- Treating anemia only with iron or vitamins without confirming whether hemolysis is present.
- Treating cold-induced color change as isolated Raynaud phenomenon without checking hemoglobin and hemolysis markers.
- Not warming samples, infusions, or transfusions when needed, causing symptoms or lab errors.
- Not evaluating for infection, autoimmune disease, or lymphoproliferative disease after CAD is diagnosed.
Departments to Start With
- Hematology
- Rare blood disease clinic
- Rheumatology and immunology
- Emergency medicine
Before the Visit
- Record when anemia was found, cold triggers, seasonal pattern, urine color, jaundice, extremity color changes, and infection history.
- Bring CBC, reticulocyte count, bilirubin, LDH, haptoglobin, direct antiglobulin test, and cold agglutinin titer.
- List transfusions, medicines, vaccines or infections, autoimmune disease, enlarged lymph nodes, spleen findings, and prior cancer or blood disease.
- Record cold workplace, freezer exposure, winter outdoor exposure, cold water, or cold drink triggers.
Tests to Ask About
- CBC, reticulocyte count, blood smear, and hemolysis markers.
- Direct antiglobulin test, especially complement C3d results, plus cold agglutinin titer and thermal amplitude when available.
- Immunoglobulins, serum protein electrophoresis or immunofixation, complement testing, and screening for lymphoproliferative disease.
- Testing for infection, autoimmune disease, bone marrow involvement, or imaging when clinically indicated.
Questions for the Doctor
- Is my anemia caused by cold agglutinins, and is it primary or secondary?
- Which temperatures, settings, infusions, or procedures require warming precautions?
- Do I only need monitoring and warmth, or do I need medicine or transfusion support?
- If I need transfusion, should the blood and infusion process be warmed?
- Should I be screened for lymphoproliferative disease, infection, or autoimmune disease, and which labs should be followed?
Basic Information
Medical Notes
More complete medical explanations are kept here for discussion with clinicians.
Symptoms
Cold agglutinin disease can cause anemia and cold-related circulation symptoms. Anemia may cause fatigue, dizziness, palpitations, shortness of breath with activity, or pallor. Hemolysis can cause jaundice, dark urine, and elevated bilirubin. Symptoms may worsen in cold seasons, after infection, or with cold exposure.
Some people develop blue or pale painful fingers, toes, ears, or nose after cold exposure. Severe hemolysis, thrombosis risk, or an associated condition requires hematology assessment.
Diagnosis
Diagnosis requires evidence of hemolytic anemia and cold agglutinin involvement. Common tests include CBC, reticulocyte count, bilirubin, LDH, haptoglobin, blood smear, direct antiglobulin test, and cold agglutinin titer.
Clinicians also look for primary CAD versus secondary disease related to infection, autoimmune disease, lymphoproliferative disease, or other causes. Blood sample handling, transport, and transfusion may need warming to reduce lab artifacts and symptom triggers.
Treatment
Mild or asymptomatic disease may be managed with cold avoidance, warming strategies, infection prevention, and monitoring hemoglobin and hemolysis markers. Before surgery, infusions, or transfusions, patients should tell the care team so warming precautions can be planned.
Symptomatic anemia, transfusion dependence, or significant cold-related circulatory symptoms may be treated with hematology-directed B-cell therapy, complement-directed therapy, or other options. Standard steroids often have limited benefit in typical CAD, so treatment should be individualized by hematology.
Long-term Care
Long-term care includes periodic CBC, hemolysis markers, complement-related testing when useful, and reassessment for underlying disease. Practical warming strategies include avoiding cold drinks, cold water immersion, cold workplaces, and unwarmed infusions.
Before travel, surgery, dental work, or endoscopy, patients should disclose the CAD diagnosis so temperature management and transfusion plans can be arranged.
Fertility and Family
Cold agglutinin disease is usually not inherited, so relatives generally do not need genetic screening. If CAD is associated with autoimmune disease, infection, or lymphoproliferative disease, family history and risk assessment follow that condition.
Pregnancy planning or active hemolysis during pregnancy should be managed jointly by hematology and obstetrics, especially if immune therapy is being used.
When to Seek Urgent Care
Seek emergency care for sudden severe shortness of breath, chest pain, fainting, confusion, very fast heartbeat, markedly darker urine with worsening weakness, fever or chills, severe limb pain, or possible blood clot symptoms. Tell the emergency team about CAD and recent medicines or transfusions.
Prognosis
The course varies. Many people reduce risk with temperature management and hematology follow-up, while severe hemolysis, transfusion dependence, or associated disease may require more active treatment.